Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J Pediatr ; 166(5): 1145-1151.e3, 2015 May.
Article in English | MEDLINE | ID: mdl-25919724

ABSTRACT

OBJECTIVE: To estimate the health and economic impact of feeding partially hydrolyzed formula-whey (PHF-W) instead of standard cow's milk formula (CMF) for the first 4 months of life among US infants at high risk for developing atopic dermatitis (AD). STUDY DESIGN: A Markov model was developed integrating published data, a survey of US pediatricians, costing sources and market data, and expert opinion. Key modeled outcomes included reduction in AD risk, time spent post AD diagnosis, days without AD flare, and AD-related costs. Costs and clinical consequences were discounted at 3% annually. RESULTS: An estimated absolute 14-percentage point reduction in AD risk was calculated with the use of PHF-W compared with CMF (95% CI for difference, 3%-22%). Relative to CMF, PHF-W decreased the time spent post-AD diagnosis by 8.3 months (95% CI, 2.78-13.31) per child and increased days without AD flare by 39 days (95% CI, 13-63) per child. The AD-related, 6-year total cost estimate was $495 less (95% CI, -$813 to -$157) per child with PHF-W ($724 per child; 95% CI, $385-$1269) compared with CMF ($1219 per child; 95% CI, $741-$1824). CONCLUSION: Utilization of PHF-W in place of CMF as the initial infant formula administered to high-risk US infants not exclusively breastfed during the first 4 months of life may reduce the incidence and economic burden of AD. Broad implementation of this strategy could result in a minimum savings of $355 million per year to society.


Subject(s)
Dermatitis, Atopic/chemically induced , Dermatitis, Atopic/economics , Infant Formula , Milk Hypersensitivity/epidemiology , Milk Proteins/chemistry , Animals , Child , Child, Preschool , Cohort Studies , Cost of Illness , Cost-Benefit Analysis , Humans , Infant , Infant, Newborn , Markov Chains , Milk/adverse effects , Models, Theoretical , Risk Factors , Treatment Outcome , Whey Proteins
2.
J Pediatr ; 163(6): 1747-53, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23953725

ABSTRACT

OBJECTIVE: To describe atopic dermatitis (AD) management patterns in children ≤36 months old as reported by pediatricians, dermatologists, and allergists in the US. STUDY DESIGN: A nationally-representative survey was administered to pediatricians (n = 101), dermatologists (n = 26), and allergists (n = 26). Main outcomes included referrals to health care professionals, suggested/ordered laboratory tests, management approach (dietary, pharmacologic, or combination of both) by age, AD location, and severity. RESULTS: Significant differences were observed in referrals to healthcare professionals (P < .001). Pediatricians more frequently referred to dermatologists than allergists in mild (52.4% vs 32.0%) and moderate/severe (60.6% vs 38.1%) cases. Dermatologists referred to allergists less frequently for mild (9.1%) than moderate/severe (40.7%) AD cases. Pediatricians (59%), allergists (61.5%), and dermatologists (26.9%) reported treating at least some of their patients with AD with dietary management (infant formula change) alone (with or without emollients). Soy-based formulas were often used. For mild AD, the most commonly reported first-line pharmacologic treatments included topical emollients, topical corticosteroids, and barrier repair topical therapy/medical devices. Over 80% of physicians used a dietary and pharmacologic combination approach. Dermatologists were most likely to manage AD symptoms with a pharmacologic-only approach. AD lesion location influenced pharmacologic treatment in >80% of physicians. CONCLUSIONS: Significant and distinct differences in AD treatment approach exist among physicians surveyed. Most pediatricians and allergists use formula change as a management strategy in some patients, whereas dermatologists favor a pharmacologic approach. This diversity may result from inadequate evidence for a standard approach. Consistent methods for managing AD are needed.


Subject(s)
Allergy and Immunology , Dermatitis, Atopic/therapy , Dermatology , Pediatrics , Practice Patterns, Physicians' , Child, Preschool , Female , Humans , Infant , Male , United States
3.
J Obes ; 2012: 123023, 2012.
Article in English | MEDLINE | ID: mdl-22675610

ABSTRACT

Childhood obesity is currently one of the most prevailing and challenging public health issues among industrialized countries and of international priority. The global prevalence of obesity poses such a serious concern that the World Health Organization (WHO) has described it as a "global epidemic." Recent literature suggests that the genesis of the problem occurs in the first years of life as feeding patterns, dietary habits, and parental feeding practices are established. Obesity prevention evidence points to specific dietary factors, such as the promotion of breastfeeding and appropriate introduction of nutritious complementary foods, but also calls for attention to parental feeding practices, awareness of appropriate responses to infant hunger and satiety cues, physical activity/inactivity behaviors, infant sleep duration, and family meals. Interventions that begin at birth, targeting multiple factors related to healthy growth, have not been adequately studied. Due to the overwhelming importance and global significance of excess weight within pediatric populations, this narrative review was undertaken to summarize factors associated with overweight and obesity among infants and toddlers, with focus on potentially modifiable risk factors beginning at birth, and to address the need for early intervention prevention.

4.
JPEN J Parenter Enteral Nutr ; 36(1 Suppl): 76S-80S, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22237881

ABSTRACT

This article reviews the factors contributing to early childhood obesity and the options for recognition and early intervention. The role for developing preschool wellness programs that incorporate nutrition education and physical activity is presented with a model under development in the state of Maryland.


Subject(s)
Child Nutritional Physiological Phenomena , Early Medical Intervention , Obesity/prevention & control , Child , Guidelines as Topic , Health Education , Health Promotion , Humans , Maryland , Motor Activity , Nutrition Policy
7.
Adolesc Med Clin ; 15(1): 105-17, ix-x, 2004 Feb.
Article in English | MEDLINE | ID: mdl-15272259

ABSTRACT

The allergic bowel diseases of the adolescent have been traditionally lumped under the diagnosis of allergic or eosinophilic gastroenteritis. Over the past 20 years, clinical criteria have been established to distinguish three distinct clinical syndromes: eosinophilic esophagitis, eosinophilic gastroenteritis, and eosinophilic ascites. Each has a characteristic infiltration of eosinophils in, respectively,the esophagus only, the stomach, small bowel, and/or large bowel, or the serosal surface of the bowel. These conditions are distinguished by clinical presentation, diagnostic features, and treatment alternatives. Teenagers with these conditions may present to their pediatrician, family physician, allergist, or gastroenterologist, so each physician must appreciate the extent of appropriate diagnostic investigations and the relative value of dietary or anti-inflammatory therapy.


Subject(s)
Eosinophilia/diagnosis , Eosinophilia/therapy , Gastroenteritis/diagnosis , Gastroenteritis/therapy , Adolescent , Adolescent Health Services , Child , Humans
8.
J Pediatr Gastroenterol Nutr ; 39(1): 15-27, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15187775

ABSTRACT

Impairment of growth and malnutrition are significant complications of inflammatory bowel disease (IBD) in pediatric patients. Since this topic was last reviewed in these pages (), a number of studies have further explored the epidemiology and pathogenesis of these nutritional complications of IBD in an effort to provide more effective interventions to prevent the long-term consequences of chronic nutrient deficiencies in childhood. In addition, during the past 15 years, the use of selected nutrients and microorganisms (probiotics) as primary or adjunctive therapy for the treatment of IBD has become an emerging area of great interest. The following is a Clinical Report from the Nutrition and Inflammatory Bowel Disease Committees of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.


Subject(s)
Child Nutritional Physiological Phenomena , Inflammatory Bowel Diseases/therapy , Nutritional Status , Nutritional Support , Body Height , Child , Chronic Disease , Gastroenterology , Humans , Inflammatory Bowel Diseases/epidemiology , Inflammatory Bowel Diseases/physiopathology , Inflammatory Bowel Diseases/psychology , North America , Nutritional Requirements , Quality of Life , Societies, Medical
SELECTION OF CITATIONS
SEARCH DETAIL
...